Evidence map›Paper›PMID 24275268›Full record

ReviewInfectious disease clinics of North America2013

Trichomoniasis: the "neglected" sexually transmitted disease.

Elissa Meites

Open access · greenAbstract readReview
In one paragraph

Review in Infectious disease clinics of North America, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
2.4field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 51 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Prevalence and Genotype ofJournal of tropical medicine · 2023
    Article
  10. Secnidazole: a treatment for trichomoniasis in adolescents and adults.Expert review of anti-infective therapy · 2022
    Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Why Does Trichomonas vaginalis Continue to be a "Neglected" Sexually Transmitted Infection?Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2018
    Article
  16. Article
  17. Review
  18. Article
  19. A Review of Evidence-Based Care of Symptomatic Trichomoniasis and Asymptomatic Trichomonas vaginalis Infections.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2015
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Elissa MeitesDivision of STD Prevention, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, 1600 Clifton Road Northeast, MS E-02, Atlanta, GA 30333, USA. Electronic address: emeites@cdc.gov.
Centers for Disease Control and Prevention · US

Funding

Intramural CDC HHS CC999999
6 · The paper itself

Abstract

Trichomonas vaginalis is the most prevalent nonviral sexually transmitted infection, affecting an estimated 3.7 million people in the United States. Although trichomoniasis is common, it has been considered a "neglected" sexually transmitted disease, due to limited knowledge of its sequelae and associated costs. This article reviews current epidemiology, pathophysiology, diagnostic methods, clinical management recommendations and special considerations, research on associated conditions and costs, prevention strategies, and controversies regarding trichomoniasis.

Indexed as

Neglected DiseasesSexually Transmitted DiseasesTrichomonas VaginitisAntiprotozoal AgentsFemaleHumansPrevalenceTrichomonas vaginalisUnited StatesAntiprotozoal AgentsNitroimidazolesNucleic acid amplification testsSexually transmitted diseaseTrichomonas vaginalisUrethritisVaginitis

Identifiers

PMID24275268
PMCPMC4677781
OpenAlexW188662491

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.